NDC 70677-0152-01 - Ibuprofen Oral
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70677-0152
- Requested NDC
- 70677-0152-01
- Package NDCs from labels
- 70677-0152-1, 70677-0152-01
- Manufacturer
- Strategic Sourcing Services | AptaPharma Inc.
- Effective date
- 2022-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen Oral Suspension USP, 100 mg/5 mL (OTC) | Strategic Sourcing Services | AptaPharma Inc. | 2022-08-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70677-0152-1 | Ibuprofen Oral | 1 in 1 CARTON | SUSPENSION | 1 | 1 | |
| 70677-0152-1 | Ibuprofen Oral | 118 mL in 1 BOTTLE | SUSPENSION | 118 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70677-0152 | IBUPROFEN ORAL (IBUPROFEN ORAL) SUSPENSION [STRATEGIC SOURCING SERVICES] | 1 | Current NDC, Legacy NDC, 2 package rows | 20220811_a3062142-db0e-4758-a762-2b2bb05670b1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70677-0152-1 | ML - Milliliter | 70677-0152 | bb59880f-140d-48e5-abd1-1bd53821bd87 | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Systane Lubricant | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 15bc06ec-f3dc-3180-ca1a-106769a770ea | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane ULTRA | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a5c1c194-3db5-4f18-9cd1-97f7f84c3cff | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 7eaa93ca-c843-4c89-921b-c76659410dce | 2023-12-14 | Warnings | 6DC9Q167V3 |
| GenTeal Tears Gel Drops | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 84388a75-9d11-48ce-bf5a-88f0580d2d03 | 2023-12-14 | Warnings | 6DC9Q167V3 |
| Ibuprofen | IBUPROFEN | A-S Medication Solutions | f1f1e0ac-6944-4123-9e08-1df91582d457 | 2023-12-13 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 Skin Protectant | GLYCERIN | L'Oreal USA Products Inc | 32eaaaab-41bd-4efe-a71d-92e3a702c1e5 | 2023-12-11 | Warnings | PDC6A3C0OX |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2023-12-11 | Warnings | PDC6A3C0OX |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 | GLYCERIN | Cosmetique Active Production | 01c8a0d5-bcd1-4639-be45-530a226401f0 | 2023-12-11 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | A-S Medication Solutions | 8553e29a-7f6f-4ff8-9991-836e619c504d | 2023-12-10 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Childrens Ibuprofen | IBUPROFEN | American Health Packaging | bc69d88b-d9af-4010-8e8f-e761a9e295a9 | 2023-12-05 | Warnings | ANDA210602 197803 WK2XYI10QM |
| Hemorrhoidal Pain Relief Cream | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | WALGREENS | 03bbe146-f185-bcfa-e063-6394a90a85bf | 2023-12-04 | Warnings | PDC6A3C0OX |
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Bloop Hemorrhoid Relief Topical | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | Three Nations Corp | 0b6419e3-f1c7-bdfe-e063-6294a90a5d92 | 2023-11-30 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | A-S Medication Solutions | 7152b6ce-6113-4003-bf80-aa263be69392 | 2023-11-24 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | A-S Medication Solutions | 400faee1-f662-470e-bcd6-7711dfaf9ba2 | 2023-11-24 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Childrens Ibuprofen | IBUPROFEN | Chain Drug Marketing Association Inc. | e210c707-2bae-44a5-93dc-459dd24fd960 | 2023-11-20 | Warnings | 197803 WK2XYI10QM |
| Saccharum officinale | SUCROSE | Boiron | 86d04552-b31a-0fcf-e053-2991aa0acecd | 2023-11-14 | C151H8M554 | |
| Saccharum officinale | SUCROSE | Boiron | 86d05561-6f09-6f1f-e053-2a91aa0a4b98 | 2023-11-14 | C151H8M554 | |
| Childrens Ibuprofen | IBUPROFEN | Chain Drug Marketing Association Inc. | c7e59784-a338-4922-a806-98c7505957cd | 2023-11-10 | Warnings | 197803 WK2XYI10QM |
| Concentrated ibuprofen infants | IBUPROFEN | Chain Drug Marketing Association Inc. | c9ae72d8-d205-4736-9bc4-2325cd77d36b | 2023-11-03 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.